Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Impact of Inotersen on Subgroups of Patients with Hereditary TTR Amyloidosis: Results from a Double-Blind Placebo-Controlled Trial

Aaron Yarlas, PhD, Giampaolo Merlini, MD, Michelle K White, PhD, Asia Sikora Kessler, PhD, Andrew Lovley, MA, Spencer D Guthrie, MPH, MBA, Michael Pollock, Morie A. Gertz, MD

Blood (2018) 132 (Supplement 1): 4803.

https://doi.org/10.1182/blood-2018-99-119216

Published: 2018

Journal Articles

Momelotinib Treatment-Associated Neuropathy: Prevalence, Risk Factors and Outcome in 100 Patients with Myelofibrosis

Ramy A. Abdelrahman, MBBCh, Kebede Begna, MD, Aref Al-Kali, MD, William J. Hogan, MBChB, Mark Litzow, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2014) 124 (21): 1837.

https://doi.org/10.1182/blood.V124.21.1837.1837

Published: 2014

Journal Articles

Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria

S. Alexander Holme, Mark Worwood, Alexander V. Anstey, George H. Elder, Michael N. Badminton

Blood (2007) 110 (12): 4108–4110.

https://doi.org/10.1182/blood-2007-04-088120

Published: 2007

Includes: Supplemental data

Journal Articles

The Role of Soluble Fibrin and Fibrin Inhibitory Peptides in Cancer Metastasis.

Brandy L. Weidow, BS, Jacqueline Vidosh, B.S., John P. Biggerstaff, Ph.D.

Blood (2006) 108 (11): 5200.

https://doi.org/10.1182/blood.V108.11.5200.5200

Published: 2006

Journal Articles

A Multicenter Phase II Trial of Bortezomib in Patients with Previously Untreated Multiple Myeloma: Efficacy with Manageable Toxicity in Patients with Unexpectedly High Rates of Baseline Peripheral Neuropathy.

Blood (2005) 106 (11): 2548.

https://doi.org/10.1182/blood.V106.11.2548.2548

Published: 2005

NARROW

Impact of Inotersen on Subgroups of Patients with Hereditary TTR Amyloidosis: Results from a Double-Blind Placebo-Controlled Trial

Momelotinib Treatment-Associated Neuropathy: Prevalence, Risk Factors and Outcome in 100 Patients with Myelofibrosis

Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria

The Role of Soluble Fibrin and Fibrin Inhibitory Peptides in Cancer Metastasis.

A Multicenter Phase II Trial of Bortezomib in Patients with Previously Untreated Multiple Myeloma: Efficacy with Manageable Toxicity in Patients with Unexpectedly High Rates of Baseline Peripheral Neuropathy.

Email alerts

ASH Publications

American Society of Hematology

Impact of Inotersen on Subgroups of Patients with Hereditary TTR Amyloidosis: Results from a Double-Blind Placebo-Controlled Trial

Momelotinib Treatment-Associated Neuropathy: Prevalence, Risk Factors and Outcome in 100 Patients with Myelofibrosis

Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria

The Role of Soluble Fibrin and Fibrin Inhibitory Peptides in Cancer Metastasis.

A Multicenter Phase II Trial of Bortezomib in Patients with Previously Untreated Multiple Myeloma: Efficacy with Manageable Toxicity in Patients with Unexpectedly High Rates of Baseline Peripheral Neuropathy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only